Daiichi Sankyo Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Other-Current-Liabilities" stands at 111.24 Billion Japanese Yens as of 06/30/2025, the highest value since 06/30/2020.
As of the end of Daiichi Sankyo Co. Ltd.'s first quarter, the item "Other Current Liabilities" stands at 111.24 Billion JPY. This represents an increase of 22.24 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 58.38 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 58.38 Billion Japanese Yens.
The 3 year change is 61.92 Billion Japanese Yens.
The 5 year change is 83.69 Billion Japanese Yens.
The 10 year change is 111.15 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Other Current Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Other Current Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Current Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Current Liabilities | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Current Liabilities | 280,205,508,085.11 |